低分子干素治疗冠脉综合症的临床分析

Dry Low Molecular Therapy for Clinical Analysis of Coronary Syndrome(ACS)

目的按照综合性的低分子肝素临床治疗冠脉综合征的相关原发性原理,合理的加强临床治疗过程的技术分析,保证合理的安全临床治疗过程中的有效低分子肝素临床性的治疗过程。方法通过对相关性的低分子肝素控制,实现合理的低分子肝素治疗问题分析。结果合理的分析临床试验中相关的低分子肝素冠脉综合症的分析,完善总体的临床性分析。结论完成认识临床上对低分子肝素对冠脉综合症的影响,保证合理的综合治疗效果。

Objective According to the comprehensive low molecular heparin associated clinical treatment of coronary syndrome of primary principle, reasonable strengthening the technical analysis of the clinical treatment process, ensure the reasonable safe effective low molecular heparin in the process of clinical treatment of the clinical treatment process, strengthening clinical treatment process. Methods Based on the correlation of low molecular heparin control, realize the reasonable analysis of the low molecular heparin treatment problem.Results The rational analysis of the clinical trial related analysis of low molecular heparin coronary syndrome （ACS）, improve the overall clinical analysis.Conclusion The complete understanding of low molecular heparin on clinical coronary syndrome （ACS）, the influence of reasonable comprehensive treatment effect.